Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Puma Breaks A Long Losing Streak For Sponsors At ODAC

Jun 04 2017

• By Michael McCaughan

FDA entrance sign 2016

Related Content

Onyx’s Myeloma Drug <em>Kyprolis</em> Fits ODAC’s View On Accelerated Approval

Jun 25 2012

Neratinib’s FDA Panel Nod Weighed Down By Indication Breadth Worries

May 25 2017

Unmet Need Can Trump Anything At US FDA Panels, Even An Ill-Prepared Sponsor

May 31 2017

US FDA Advisory Committee Drought Is Over … Unless Sponsors Are Scared Of Dark Clouds

Mar 28 2017

Related Companies

Emmaus Life Sciences, Inc.

Puma Biotechnology, Inc.

Genentech, Inc.

Amgen, Inc.

Onyx Pharmaceuticals, Inc.

AVEO Pharmaceuticals, Inc.

Clovis Oncology, Inc.

Spectrum Pharmaceuticals, Inc.

Novartis AG

AstraZeneca PLC

Array BioPharma, Inc.

Roche Holding AG

Rockwell Medical Inc.

Novartis AG

Eli Lilly and Company

Additional Topics

United States Advisory Committees Drug Approval Standards FDA Cancer BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window